Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation Molecule-Reference-Cited by-同舟云学术

Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation Molecule

Published:1992-08-07 Issue:5071 Volume:257 Page:792-795
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Linsley Peter S.¹,Wallace Philip M.¹,Johnson Jennifer¹,Gibson Marylou G.¹,Greene JoAnne L.¹,Ledbetter Jeffrey A.¹,Singh Cherry²,Tepper Mark A.²

Affiliation:

1. Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121.

2. Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 06492.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference28 articles.

1. BIERER, B.E., T-CELL RECEPTORS - ADHESION AND SIGNALING, ADVANCES IN CANCER RESEARCH 56: 49 (1991).

2. BRUNET, J.F., A NEW MEMBER OF THE IMMUNOGLOBULIN SUPERFAMILY - CTLA-4, NATURE 328: 267 (1987).

3. BURSTEIN, H.J., AQUEOUS ANTIGENS INDUCE INVIVO TOLERANCE SELECTIVELY IN IL-2-GAMMA-PRODUCING AND IFN-GAMMA-PRODUCING (TH1) CELLS, JOURNAL OF IMMUNOLOGY 148: 3687 (1992).

4. DAMLE, N.K., DIRECT HELPER T-CELL-INDUCED B-CELL DIFFERENTIATION INVOLVES INTERACTION BETWEEN T-CELL ANTIGEN-CD28 AND B-CELL ACTIVATION ANTIGEN-B7, EUROPEAN JOURNAL OF IMMUNOLOGY 21: 1277 (1991).

5. FREEMAN, G.J., STRUCTURE, EXPRESSION, AND T-CELL COSTIMULATORY ACTIVITY OF THE MURINE HOMOLOG OF THE HUMAN LYMPHOCYTE-B ACTIVATION ANTIGEN-B7, JOURNAL OF EXPERIMENTAL MEDICINE 174: 625 (1991).

Cited by 756 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitors for Pediatric Cancers: Is It Still a Stalemate?;Pharmaceuticals;2024-07-26

2. Sequential immunotherapy: towards cures for autoimmunity;Nature Reviews Drug Discovery;2024-06-05

3. IL-6 inhibition prevents costimulation blockade-resistant allograft rejection in T cell-depleted recipients by promoting intragraft immune regulation in mice;Nature Communications;2024-06-03

4. Immune checkpoint molecules in solid organ transplantation: A promising way to prevent rejection;Immunology Letters;2024-06

5. Autoimmune Responses and Therapeutic Interventions for Systemic Lupus Erythematosus: A Comprehensive Review;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-04